logo
episode-header-image
Sep 2021
21m 18s

The Innovation System Behind Moderna’s C...

Harvard Business Review
About this episode
Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s Covid-19 vaccine came not as a stroke of luck, but from a repeatable process. He outlines a system called “emergent discovery” that involves working back from future ideals, pioneering in novel spaces, encourag ... Show More
Up next
Jan 2020
How to Capture All the Advantages of Open Innovation
23m 57s
Jan 2020
Revisiting “Jobs To Be Done” with Clayton Christensen
25m 46s
Aug 18
Living and Working in the Age of Longevity
People are living longer, healthier lives than ever before. But many of our assumptions about executive careers—from climbing the corporate ladder to retiring at 65—haven't caught up. London Business School professor Lynda Gratton says we need a new way of thinking about work and ... Show More
28m 57s
Recommended Episodes
Oct 2021
Moderna and Flagship Pioneering: Noubar Afeyan
In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his colleagues were looking for a w ... Show More
1h 6m
Aug 2021
Noubar Afeyan
Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.See ... Show More
22m 42s
May 2022
Extraordinary leaps need solid foundations, part 1, w/Moderna CEO Stéphane Bancel
If you're launching a moonshot, success depends on how you manage the trajectory of risk. When Stéphane Bancel became Moderna's first CEO, the biotech start-up was chasing a way-out idea many experts thought was impossible. Stéphane built a culture of calculated risk-taking to cr ... Show More
34m 3s
Mar 2025
Stéphane Bancel: “The upside was changing humanity forever.”
Moderna’s CEO Stéphane Bancel will go down in history for pioneering the Covid-19 vaccine. He sits down with Bob to recount the story of the pandemic from his perspective, from the moment he knew it would become an international disaster to the decision to throw out Moderna’s pla ... Show More
34m 3s
Jun 2021
Moderna: The Software of Life - [Business Breakdowns, EP. 13]
Today, we will be diving into Moderna. Founded in 2010, Moderna and its innovative RNA platform made headlines after developing one of the first COVID vaccines. We treated this Breakdown slightly different than our other episodes. I’m joined today by two guests. First, I am joine ... Show More
1h 9m
Sep 2021
The future of vaccines
The founders of German biotechnology company BioNTech were researching how to fight cancers using messenger RNA, "the unloved cousin of DNA", when covid-19 first appeared and they realised mRNA could be used to make a vaccine for the disease. Financial Times journalist Joe Miller ... Show More
17m 28s
Feb 2024
Moderna and Drug Discovery With AI
Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ... Show More
36m 35s
Jul 2024
Innovating Around an Existing Core Product or Service
What do LEGO, GoPro, and CarMax have in common? Wharton professor David Robertson says they all have a similar strategy for growth that involves building families of complementary innovations around a core product or service. It’s an approach to innovation that’s neither disrupti ... Show More
25m 23s
Dec 2020
The mRNA Breakthrough
How do you fight a pandemic? With cutting edge technology. Two of the new Covid-19 vaccines applying for FDA approval rely on a novel approach that uses mRNA to turn the human body into an internal vaccine factory. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to mRNA re ... Show More
9m 12s
Dec 2024
A New Model for Funding Healthcare Innovation
Entrepreneur Duke Rohlen creates California-based Ajax Health under a new model. Partnering with private equity firms, Rohlen considers a $1 billion bid to buy medical device maker Cordis. If Ajax’s bid is successful, they will invest an additional $300 million to fund an acceler ... Show More
38m 32s